The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Weight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...

CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

A decision is expected in the fourth quarter of 2025.

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Wegovy versus Ozempic for weight loss — it’s the age-old question. Okay, not that old. But it’s a common question amid the rising popularity of these weight loss drugs. Wegovy and Ozempic ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.